Profil
Kirk Bertelsen currently works at Viridian Therapeutics, Inc., as Senior VP & Head-Research from 2024.
Dr. Bertelsen also formerly worked at Magenta Therapeutics, Inc., as Head-Clinical Pharmacology.
Dr. Bertelsen received his undergraduate degree from the University of Oregon and doctorate degree from Sackler School of Graduate Biomedical Sciences.
Aktive Positionen von Kirk Bertelsen
| Unternehmen | Position | Beginn |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2024 |
Ehemalige bekannte Positionen von Kirk Bertelsen
| Unternehmen | Position | Ende |
|---|---|---|
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Ausbildung von Kirk Bertelsen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sackler School of Graduate Biomedical Sciences
Sackler School of Graduate Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
















